Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
The Mayo Clinic shares that those most at risk of low levels include (5): people who dont consume enough vitamin B12 in their diet people diagnosed with pernicious anemia people whove had gastric surgeries people with intestinal issues, such as celiac or Crohns disease People following a vegetarian diet are especially at risk of deficiency
A cloudy solution should not be used in experiments, especially cell culture, as the cause is unknown and could introduce artifacts or toxicity
Side effects are reported as anecdotes
FOXO4-DRI acts as a competitive inhibitor of this interaction binding directly to the transactivation domain 2 (TAD2) of p53, displacing FOXO4, and allowing phosphorylated p53 to be exported from the nucleus and directed to mitochondria, where it activates BAX, triggers caspase-3 cleavage (via the p53/BCL-2/Caspase-3 signalling pathway), and drives cell-intrinsic apoptosis
Identity, purity, and formulation uncertainty Beyond intrinsic pharmacology sit the practical hazards of the research-chemical market
Two people, no controls, no oral or subcutaneous data
US$ 24.19
US$ 24.03
US$ 21.17
US$ 25.08
US$ 27.58
